Cibra Capital LTD
Cibra Capital LTD is an exempt reporting adviser based in London, United Kingdom that reports managing 1 hedge fund on Form ADV. Its disclosed U.S. stock holdings returned an estimated -4.3% 2026 YTD through Mar 31 (S&P 500: -4.6%), based on 13F filings. Over a longer period they returned an estimated -4.1% from Q1 2025 to Q1 2026, compared with -9.0% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- —Form ADV Item 5.F
- Gross assets of private funds
- $0All private fund types, Form ADV
- Hedge funds managed
- 11 private funds in total
- Employees
- —Form ADV Item 5.A
- Registration
- Exempt reporting adviserCRD 334693
- Latest Form ADV
- 03/30/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q1 2026 | -4.3% | -4.6% |
| Q1 2025 | +0.2% | -4.5% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Largest disclosed holdings
- Amicus Therapeutics Inc$24.4 million
- Sealed Air Corp New Com$21.6 million
- Txnm Energy Inc$16.6 million
- Masimo Corp$16.1 million
- Hologic Inc$15.8 million
- Allied Gold Corp$13.1 million
- Onestream Inc$12.5 million
- Clearwater Analytics Hldgs I$10.8 million
- Penumbra Inc$10.4 million
- Arcellx Inc Common Stock$10.2 million
As of 2026-03-31, from 13F filing by CIBRA Capital Ltd.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures